ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 50, 2015, Pages E7003-E7012

  Sequeira, Vasco ^a   Najafi, Aref ^a   Wijnker, Paul J M ^a   Dos Remedios, Cristobal G ^b   Michels, Michelle ^c   Kuster, Diederik W D ^a   Van Der Velden, Jolanda ^a,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

ADP; Cardiomyopathy; Hypertrophy; Idiopathic dilated; Three state model

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; ADENOSINE DIPHOSPHATE; CALCIUM ION; CARDIAC MYOSIN BINDING PROTEIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE; MUSCLE PROTEIN; MUTANT PROTEIN; MYBPC3 PROTEIN; MYH7 PROTEIN; MYOSIN; MYOSIN BINDING PROTEIN C; PROTEIN ANTIBODY; TNNT2 PROTEIN; TROPOMYOSIN; TROPONIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTERIAL STIFFNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCE; HEART; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; INCUBATION TIME; MISSENSE MUTATION; MYOFILAMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SARCOMERE; THIN FILAMENT; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

ADENOSINE DIPHOSPHATE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HEART DISEASES; HUMANS; MYOCARDIAL CONTRACTION; PHOSPHORYLATION;

EID: 84950315474     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1513843112     Document Type: Article

References (67)

1. Dickstein K, et al.; ESC Committee for Practice Guidelines (CPG) (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388-2442
2. and correction (2010) 31(5):624.
3. Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment. Eur Heart J 32(6):670-679.
4. Tardiff JC, et al. (2015) Targets for therapy in sarcomeric cardiomyopathies. Cardiovasc Res 105(4):457-470.
5. Hamdani N, et al. (2008) Sarcomeric dysfunction in heart failure. Cardiovasc Res 77(4):649-658.
6. Cazorla O, et al. (2006) Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res 69(2):370-380.
7. Konhilas JP, et al. (2003) Troponin I in the murine myocardium: Influence on lengthdependent activation and interfilament spacing. J Physiol 547(Pt 3):951-961.
8. Stelzer JE, Patel JR, Moss RL (2006) Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ Res 99(8):884-890.
9. Wijnker PJM, et al. (2014) Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation. Am J Physiol Heart Circ Physiol 306(8):H1171-H1181.
10. Sequeira V, et al. (2013) Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res 112(11):1491-1505.
11. McKillop DF, Geeves MA (1993) Regulation of the interaction between actin and myosin subfragment 1: Evidence for three states of the thin filament. Biophys J 65(2):693-701.
12. Lehman W, et al. (2000) Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J Mol Biol 302(3):593-606.
13. Geeves MA, Lehrer SS (1994) Dynamics of the muscle thin filament regulatory switch: The size of the cooperative unit. Biophys J 67(1):273-282.
14. Pirani A, et al. (2005) Single particle analysis of relaxed and activated muscle thin filaments. J Mol Biol 346(3):761-772.
15. 2+. Role in spontaneous tension oscillation of skeletal muscle. Biophys J 61(5):1087-1098.
16. Fukuda N, Fujita H, Fujita T, Ishiwata S (1996) Spontaneous tension oscillation in skinned bovine cardiac muscle. Pflugers Arch 433(1-2):1-8.
17. Fukuda N, Fujita H, Fujita T, Ishiwata S (1998) Regulatory roles of MgADP and calcium in tension development of skinned cardiac muscle. J Muscle Res Cell Motil 19(8):909-921.
18. Sequeira V, et al. (2015) Synergistic role of ADP and Ca2+ in diastolic myocardial stiffness. J Physiol 593(17):3899-3916.
19. Burhop J, Rosol M, Craig R, Tobacman LS, Lehman W (2001) Effects of a cardiomyopathy-causing troponin t mutation on thin filament function and structure. J Biol Chem 276(23):20788-20794.
20. Kobayashi T, Solaro RJ (2006) Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem 281(19):13471-13477.
21. Mun JY, et al. (2011) Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C (cMyBP-C). J Mol Biol 410(2):214-225.
22. Mun JY, et al. (2014) Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism. Proc Natl Acad Sci USA 111(6):2170-2175.
23. van Dijk SJ, et al. (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: Haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119(11):1473-1483.
24. Marston S, et al. (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105(3):219-222.
25. Javadpour MM, Tardiff JC, Pinz I, Ingwall JS (2003) Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest 112(5):768-775.
26. Spindler M, et al. (1998) Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest 101(8):1775-1783.
27. He H, Javadpour MM, Latif F, Tardiff JC, Ingwall JS (2007) R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. Biophys J 93(5):1834-1844.
28. Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415(6868):198-205.
29. Swiderek K, Jaquet K, Meyer HE, Heilmeyer LMG (1988) Cardiac troponin I, isolated from bovine heart, contains two adjacent phosphoserines. A first example of phosphoserine determination by derivatization to S-ethylcysteine. Eur J Biochem 176(2):335-342.
30. Swiderek K, et al. (1990) Sites phosphorylated in bovine cardiac troponin T and I. Characterization by 31P-NMR spectroscopy and phosphorylation by protein kinases. Eur J Biochem 190(3):575-582.
31. 2+-regulatory site of bovine cardiac troponin. J Biol Chem 257(1):260-263.
32. Dong W-J, et al. (1997) Phosphorylation-induced distance change in a cardiac muscle troponin I mutant. Biochemistry 36(22):6754-6761.
33. Finley N, et al. (1999) NMR analysis of cardiac troponin C-troponin I complexes: Effects of phosphorylation. FEBS Lett 453(1-2):107-112.
34. Ward DG, et al. (2004) NMR and mutagenesis studies on the phosphorylation region of human cardiac troponin I. Biochemistry 43(19):5772-5781.
35. 2+-regulated muscle relaxation at interaction sites of troponin with actin and tropomyosin. J Mol Biol 352(1):178-201.
36. Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction? EMBO J 14(9):1952-1960.
37. Shaffer JF, Kensler RW, Harris SP (2009) The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner. J Biol Chem 284(18):12318-12327.
38. Previs MJ, et al. (2013) Dephosphorylated cardiac myosin-binding protein C (cMyBP-C) activates native cardiac thin filaments within the C-zone of native cardiac thick filaments. Biophys J 104:186a.
39. Previs MJ, et al. (2015) Myosin-binding protein C corrects an intrinsic inhomogeneity in cardiac excitation-contraction coupling. Sci Adv 1(1):e1400205.
40. Starr R, Offer G (1978) The interaction of C-protein with heavy meromyosin and subfragment-2. Biochem J 171(3):813-816.
41. Gilbert R, Kelly MG, Mikawa T, Fischman DA (1996) The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle. J Cell Sci 109(Pt 1):101-111.
42. Moos C, Mason CM, Besterman JM, Feng INM, Dubin JH (1978) The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1. J Mol Biol 124(4):571-586.
43. Yamamoto K, Moos C (1983) The C-proteins of rabbit red, white, and cardiac muscles. J Biol Chem 258(13):8395-8401.
44. Stelzer JE, Dunning SB, Moss RL (2006) Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. Circ Res 98(9):1212-1218.
45. Stelzer JE, Fitzsimons DP, Moss RL (2006) Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. Biophys J 90(11):4119-4127.
46. Previs MJ, Beck Previs S, Gulick J, Robbins J, Warshaw DM (2012) Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science 337(6099):1215-1218.
47. Gruen M, Gautel M (1999) Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosinbinding protein-C. J Mol Biol 286(3):933-949.
48. Sequeira V, Witjas-Paalberends ER, Kuster DWD, van der Velden J (2014) Cardiac myosin-binding protein C: Hypertrophic cardiomyopathy mutations and structurefunction relationships. Pflugers Arch 466(2):201-206.
49. Pohlmann L, et al. (2007) Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 101(9):928-938.
50. Tobacman LS, et al. (2002) The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J Biol Chem 277(31):27636-27642.
51. Gollapudi SK, Mamidi R, Mallampalli SL, Chandra M (2012) The N-terminal extension of cardiac troponin T stabilizes the blocked state of cardiac thin filament. Biophys J 103(5):940-948.
52. Schober T, et al. (2012) Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Circ Res 111(2):170-179.
53. Tardiff JC, et al. (1999) Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 104(4):469-481.
54. Knollmann BC, et al. (2001) Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy. J Biol Chem 276(13):10039-10048.
55. Germans T, et al. (2010) How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12(1):13.
56. Nagueh SF, et al. (2001) Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104(2):128-130.
57. Papp Z, Szabó A, Barends JP, Stienen GJM (2002) The mechanism of the force enhancement by MgADP under simulated ischaemic conditions in rat cardiac myocytes. J Physiol 543(Pt 1):177-189.
58. Cooke R, Bialek W (1979) Contraction of glycerinated muscle fibers as a function of the ATP concentration. Biophys J 28(2):241-258.
59. van der Velden J, et al. (1998) Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. Cardiovasc Res 38(2):414-423.
60. Zaremba R, et al. (2007) Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl 1(10):1285-1290.
61. Page SG, Huxley HE (1963) Filament lengths in striated muscle. J Cell Biol 19(2):369-390.
62. Robinson TF, Winegrad S (1979) The measurement and dynamic implications of thin filament lengths in heart muscle. J Physiol 286:607-619.
63. Tobacman LS (1996) Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 58:447-481.
64. White SP, Cohen C, Phillips GN, Jr (1987) Structure of co-crystals of tropomyosin and troponin. Nature 325(6107):826-828.
65. Higuchi H, Yanagida T, Goldman YE (1995) Compliance of thin filaments in skinned fibers of rabbit skeletal muscle. Biophys J 69(3):1000-1010.
66. Huxley HE (1971) The structural basis of muscular contraction. Proc R Soc Lond B Biol Sci 178(1051):131-149.
67. Luther PK, et al. (2011) Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle. Proc Natl Acad Sci USA 108(28):11423-11428.